Published in Drug Alcohol Depend on March 21, 2013
Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics | NCT03220776
Multimodal assessment of primary motor cortex integrity following sport concussion in asymptomatic athletes. Clin Neurophysiol (2014) 1.46
Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Curr Addict Rep (2014) 0.87
Neurobiological signatures associated with alcohol and drug use in the human adolescent brain. Neurosci Biobehav Rev (2016) 0.83
Social Stress and Psychosis Risk: Common Neurochemical Substrates? Neuropsychopharmacology (2015) 0.80
Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. Int J Neuropsychopharmacol (2015) 0.79
Safety and Toxicology of Cannabinoids. Neurotherapeutics (2015) 0.75
Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging. Future Neurol (2015) 0.75
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun (1995) 6.55
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci (1991) 5.88
Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol (1988) 5.54
Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09
Endocannabinoid signaling in the brain. Science (2002) 4.28
WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B (1994) 3.93
Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav (2007) 3.60
Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend (2003) 2.68
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci (2007) 2.22
Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol (2010) 2.21
Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci (2001) 2.08
The developing synapse: construction and modulation of synaptic structures and circuits. Science (2002) 2.02
Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2002) 2.01
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry (2002) 1.99
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology (2003) 1.97
Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res (2005) 1.89
In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med (1990) 1.82
Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology (2009) 1.82
Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl) (1999) 1.79
The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev (2008) 1.78
Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol (2002) 1.76
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology (2002) 1.75
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol (2004) 1.67
ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed (2006) 1.67
Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry (2004) 1.42
Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med (2005) 1.39
Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (2010) 1.38
A TOTAL SYNTHESIS OF DL-DELTA-1-TETRAHYDROCANNABINOL, THE ACTIVE CONSTITUENT OF HASHISH. J Am Chem Soc (1965) 1.37
Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend (2009) 1.32
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology (2012) 1.29
Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy. NMR Biomed (2011) 1.29
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem (2007) 1.24
Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry (2011) 1.23
Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed (2005) 1.20
Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging (2007) 1.20
State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed (2011) 1.19
Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol (2010) 1.16
Assessment of adolescent neurotoxicity: rationale and methodological considerations. Neurotoxicol Teratol (2006) 1.12
Combined and independent effects of chronic marijuana use and HIV on brain metabolites. J Neuroimmune Pharmacol (2006) 1.10
Effects of age and sex on brain glutamate and other metabolites. Magn Reson Imaging (2008) 1.10
Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol Psychiatry (2007) 1.09
Use of Voigt lineshape for quantification of in vivo 1H spectra. Magn Reson Med (1997) 1.09
The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord (2007) 1.08
The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study. Neuropsychopharmacology (2012) 1.03
Long lasting consequences of cannabis exposure in adolescence. Mol Cell Endocrinol (2008) 1.02
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res (2009) 1.00
Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biol Psychiatry (2007) 0.98
Residual effects of chronic cannabis treatment on behavior in mature rats. Psychopharmacology (Berl) (1985) 0.96
Elimination of spatial interference in PRESS-localized editing spectroscopy. Magn Reson Med (2007) 0.94
Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage (2011) 0.92
MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR Biomed (2006) 0.88
Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210. Synapse (2010) 0.86
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology (2010) 0.86
Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers. J Psychopharmacol (2009) 0.83
[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Encephale (2008) 0.82
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry (2008) 3.28
Cortical and limbic activation during viewing of high- versus low-calorie foods. Neuroimage (2003) 2.71
Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med (2010) 2.50
Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes (2006) 2.42
Altitude, gun ownership, rural areas, and suicide. Am J Psychiatry (2010) 2.18
Brains on video games. Nat Rev Neurosci (2011) 2.12
The possible effect of altitude on regional variation in suicide rates. Med Hypotheses (2009) 1.99
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.94
Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry (2004) 1.89
Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res (2005) 1.89
Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Res (2010) 1.84
Acute air pollution exposure and risk of suicide completion. Am J Epidemiol (2015) 1.73
Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology (2007) 1.68
Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry (2004) 1.65
Activation of the amygdala and anterior cingulate during nonconscious processing of sad versus happy faces. Neuroimage (2004) 1.64
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60
Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord (2006) 1.59
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry (2004) 1.58
Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology (2007) 1.57
Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2004) 1.56
Functional anatomy of impaired selective attention and compensatory processing in autism. Brain Res Cogn Brain Res (2003) 1.55
Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry (2009) 1.50
Yoga Asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med (2007) 1.44
Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology (2007) 1.41
Social anxiety predicts amygdala activation in adolescents viewing fearful faces. Neuroreport (2005) 1.41
Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry (2005) 1.40
Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiatry (2010) 1.38
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
Depression like characteristics of 5HTTLPR polymorphism and temperament in excessive internet users. J Affect Disord (2007) 1.34
Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry (2002) 1.33
Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend (2009) 1.32
Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2006) 1.29
Brain activity and desire for Internet video game play. Compr Psychiatry (2011) 1.28
Decreased activation of the anterior cingulate in bipolar patients: an fMRI study. J Affect Disord (2004) 1.28
Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla. NMR Biomed (2009) 1.26
Hippocampal volume, PTSD, and alcoholism in combat veterans. Am J Psychiatry (2006) 1.24
White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Compr Psychiatry (2002) 1.22
The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder. Compr Psychiatry (2008) 1.22
Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed (2005) 1.20
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry (2005) 1.20
Abnormal T2 relaxation time in the cerebellar vermis of adults sexually abused in childhood: potential role of the vermis in stress-enhanced risk for drug abuse. Psychoneuroendocrinology (2001) 1.20
Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) (2005) 1.19
Adolescents at risk for alcohol abuse demonstrate altered frontal lobe activation during Stroop performance. Alcohol Clin Exp Res (2010) 1.19
Activation in dorsolateral prefrontal cortex in response to maternal criticism and praise in recovered depressed and healthy control participants. Biol Psychiatry (2005) 1.18
Developmental changes in the functional brain responses of adolescents to images of high and low-calorie foods. Dev Psychobiol (2005) 1.18
Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep (2008) 1.18
Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2005) 1.18
Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry (2004) 1.18
Asymmetrically altered integrity of cingulum bundle in posttraumatic stress disorder. Neuropsychobiology (2007) 1.18
Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction. Exp Clin Psychopharmacol (2010) 1.18
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict (2005) 1.17
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.16
Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol (2010) 1.16
Unconscious processing of facial affect in children and adolescents. Soc Neurosci (2007) 1.16
Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology (2005) 1.14
Neuropsychological consequences of opiate use. Neuropsychol Rev (2007) 1.13
T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magn Reson Med (2010) 1.13
Disrupted white matter tract integrity of anterior cingulate in trauma survivors. Neuroreport (2005) 1.12
Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry (2002) 1.11
Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res (2009) 1.11
Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry (2004) 1.10
fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. J Affect Disord (2006) 1.10
Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res (2004) 1.10
Body mass predicts orbitofrontal activity during visual presentations of high-calorie foods. Neuroreport (2005) 1.10
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology (2010) 1.10
Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biol Psychiatry (2002) 1.09
Sex-related developmental differences in the lateralized activation of the prefrontal cortex and amygdala during perception of facial affect. Percept Mot Skills (2004) 1.09
Cerebellar vermis involvement in cocaine-related behaviors. Neuropsychopharmacology (2006) 1.08
Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry (2006) 1.08
Ventromedial prefrontal activity correlates with depressed mood in adolescent children. Neuroreport (2006) 1.08
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry (2008) 1.08
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry (2002) 1.06
Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry (2009) 1.06
The right-hemisphere and valence hypotheses: could they both be right (and sometimes left)? Soc Cogn Affect Neurosci (2007) 1.06
Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry (2006) 1.05
Trajectories of adolescent emotional and cognitive development: effects of sex and risk for drug use. Ann N Y Acad Sci (2004) 1.05
Dopamine genes and reward dependence in adolescents with excessive internet video game play. J Addict Med (2007) 1.05
Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol Psychiatry (2006) 1.05
Factors influencing behavior in the forced swim test. Physiol Behav (2013) 1.04
Sex differences in the relationship between white matter microstructure and impulsivity in adolescents. Magn Reson Imaging (2006) 1.04
Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res (2003) 1.04
Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson (2010) 1.04
Increased Rostral Anterior Cingulate Cortex Volume in Chronic Primary Insomnia. Sleep (2013) 1.04
White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res (2004) 1.03
Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology (2010) 1.03
Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am J Psychiatry (2002) 1.03
Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Depend (2005) 1.02
Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug Alcohol Depend (2006) 1.02
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence. Exp Clin Psychopharmacol (2009) 1.02